StockTipsArenaBeta

BUY Caplin Point Laboratories Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities

BUYCaplin Point Laboratories Limited
Caplin Point Laboratories share price target & all analyst calls

bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: NA (inferred 1 year)25 Sept 2026via NDTV Profit (Live)

Entry₹2,890Inferred
Target₹3,850
Total upside +33.22% (call closed)
Stop loss₹2,379-17.68% risk
Exit₹2,37913 Oct 2026, 9:16 am
Stop-loss hit-17.68%
Follow Sachin Janardan Sarvade for new callsGet alertsWatch CAPLIPOINT for new buy/sell callsGet alertsSee 273 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Oct 2026
5 supporting3 neutral0 opposing
Supports the BUY call (5)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·24 Sept · 3w ago

Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Caplin Point Laboratories

All analyst calls on Caplin Point Laboratories

More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities

Every call and its outcome